| 03/31/2026 8:20 AM | AIkido Pharma (12239) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 03/31/2026 7:12 AM | AIkido Pharma (12239) Filer | Form 10-K Annual report pursuant to Section 13 or 15(d) | |
| 03/26/2026 8:47 PM | AIkido Pharma (12239) Subject Hayes Anthony (1538372) Filed by | Form SCHEDULE 13D/A | |
| 03/26/2026 8:48 PM | AIkido Pharma (12239) Subject Wool Kyle Michael (1856536) Filed by | Form SCHEDULE 13D/A | |
| 03/25/2026 7:10 AM | AIkido Pharma (12239) Issuer LEDWICK TIM S (1016675) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 03/24/2026 8:22 PM | AIkido Pharma (12239) Issuer Parsley Brian Keith (2088830) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 03/24/2026 8:22 PM | Blattner Gregory James (1739725) Reporting AIkido Pharma (12239) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 03/24/2026 8:22 PM | AIkido Pharma (12239) Issuer Wool Kyle Michael (1856536) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 03/24/2026 8:23 PM | AIkido Pharma (12239) Issuer Haug Kyle (2001535) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 03/24/2026 8:23 PM | AIkido Pharma (12239) Issuer Hayes Anthony (1538372) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 03/23/2026 3:30 PM | AIkido Pharma (12239) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
Get the Latest News and Ratings for AIKI and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for AIkido Pharma and its competitors with MarketBeat's FREE daily newsletter.
|
| 03/13/2026 4:24 PM | AIkido Pharma (12239) Filer | Form S-8 Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
| 02/06/2026 10:32 AM | AIkido Pharma (12239) Filer | Form DEF 14A | |
| 01/26/2026 4:11 PM | AIkido Pharma (12239) Filer | Form PRE 14A | |
| 01/08/2026 6:55 PM | AIkido Pharma (12239) Filer | Form S-8 Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
| 12/12/2025 8:48 PM | Devall Christopher Franklin (1961226) Reporting AIkido Pharma (12239) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 12/12/2025 4:19 PM | AIkido Pharma (12239) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 12/10/2025 8:20 PM | AIkido Pharma (12239) Issuer Wool Kyle Michael (1856536) Reporting | Form 4/A | |
| 12/10/2025 8:22 PM | AIkido Pharma (12239) Issuer Hayes Anthony (1538372) Reporting | Form 4/A | |
| 12/10/2025 6:52 AM | AIkido Pharma (12239) Issuer Hayes Anthony (1538372) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 12/10/2025 6:54 AM | AIkido Pharma (12239) Issuer Wool Kyle Michael (1856536) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 12/10/2025 6:56 AM | Devall Christopher Franklin (1961226) Reporting AIkido Pharma (12239) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 12/05/2025 7:56 PM | Devall Christopher Franklin (1961226) Reporting AIkido Pharma (12239) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 11/12/2025 7:00 AM | AIkido Pharma (12239) Filer | Form RW | |
| 11/10/2025 7:03 AM | AIkido Pharma (12239) Filer | Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
| 11/10/2025 7:08 AM | AIkido Pharma (12239) Filer | Form DEF 14A | |
| 11/10/2025 7:09 AM | AIkido Pharma (12239) Filer | Form ARS | |
| 10/31/2025 3:16 PM | AIkido Pharma (12239) Filer | Form PRER14A | |
| 10/20/2025 4:24 PM | AIkido Pharma (12239) Filer | Form PRE 14A | |
| 10/08/2025 3:56 PM | AIkido Pharma (12239) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 09/29/2025 3:30 PM | AIkido Pharma (12239) Issuer Parsley Brian Keith (2088830) Reporting | Form 3 Initial statement of beneficial ownership of securities | |
| 09/25/2025 4:00 PM | Blattner Gregory James (1739725) Reporting AIkido Pharma (12239) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 09/22/2025 7:05 AM | AIkido Pharma (12239) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 09/10/2025 7:00 AM | AIkido Pharma (12239) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 08/28/2025 7:01 AM | AIkido Pharma (12239) Filer | Form S-3 Registration statement under Securities Act of 1933 | |
| 08/11/2025 4:31 PM | AIkido Pharma (12239) Filer | Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
| 05/13/2025 7:15 AM | AIkido Pharma (12239) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |